搜尋結果
Beijing hospital promotes clinical trial awareness and participation
China Daily· 5 小時前"Accelerating the high-quality development of clinical trials and advancing pharmaceutical R&D and innovation act as important ...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 日前Moderna and Merck released more positive three-year data Monday on their experimental vaccine, ...
The Lens: Too many drivers, not enough demand in Chinese ride-hailing market
South China Morning Post· 3 日前As China’s ride-hailing market becomes more saturated, the negative impact of this phenomenon ...
信達生物在2024年美國臨床腫瘤學會(ASCO)年會口頭報告全球首創抗CLDN18.2/CD3雙特異性抗體(IBI389 ...
am730· 3 日前美國舊金山和中國蘇州2024年6月3日 /美通社/ -- 信達生物製藥集團(香港聯交所股票代碼:01801),一家致力於研發、生產和銷售腫瘤、自身免疫、代謝、眼科 ...
Astra's Enhertu delays breast cancer in patients with low HER2 levels
Reuters· 3 日前, opens new tab Enhertu was shown in a large trial to delay the growth of hormone-sensitive ...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 4 日前... tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed tumor ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 5 日前, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters· 5 日前, opens new tab said it expects its cancer drug Lorbrena to top $1 billion in annual sales by ...
古埃及醫學如此先進!4600年前頭骨竟找到「治癌」痕跡
巴士的報· 5 日前國際學術團隊近日在古埃及頭骨找到「治癌」痕跡,或將人類治療癌症紀錄往前推1000年。4600年前頭骨找 ...
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 5 日前In a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some ...
tumour 相關
廣告